Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maruha Nichiro is a global leader in the seafood industry that has successfully diversified into the life sciences and healthcare sectors through its Fine Chemicals business unit. The company leverages its access to marine resources to produce high-value pharmaceutical ingredients, including Heparin Sodium, Chondroitin Sulfate, and omega-3 fatty acids like DHA and EPA. Maruha Nichiro operates as a key supplier and contract manufacturer for the global pharmaceutical and nutraceutical industries, focusing on cardiovascular health, joint support, and anticoagulation therapies. The company is particularly notable for maintaining a fully traceable supply chain for Heparin, a critical anticoagulant used in surgeries and dialysis worldwide. Their healthcare operations are supported by robust R&D focused on extraction and purification technologies derived from marine origins.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maruha Nichiro.